研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2025 年的期刊文章 · 第 11 页
共 1491 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2025-08-11 到 2025-08-05。
按期刊、按主题看 →
SMMR Clinical Trials Longitudinal Data · 发表于 2025-08-11
Jingxia Liu, Fan Li, Siobhan Sutcliffe, Graham A Colditz
摘要
The optimal designs (ODs) for parallel-arm longitudinal cluster randomized trials, multiple-period cluster randomized crossover (CRXO) trials, and stepped wedge cluster randomized trials (SW-CRTs), including closed-cohort and repeat cross-sectional designs, have been studied separately under a cost-efficiency framework based on generalized estimating equations (GEEs). However, whether a global OD exists across longitudinal designs and randomization schedules remains unknown. Therefore, this research addresses a critical gap by comparing OD feature across complete longitudinal cluster randomized trial designs with two treatment conditions and continuous outcomes. We define the OD as the design with either the lowest cost to obtain a desired level of power or the largest power given a fixed budget. For each of these ODs, we obtain the optimal number of clusters and the optimal cluster-period size (number of participants per cluster per period). To ensure equitable comparisons, we consider the GEE treatment effect estimator with the same block exchangeable correlation structure and develop OD algorithms with the lowest cost for each of six study designs. To obtain OD with the largest power, we summarize the previous and propose new OD algorithms and formulae. We suggest using the number of treatment sequences L = T − 1 , where T is the number of time-periods, in both the optimal closed-cohort and repeated cross-sectional SW-CRTs to have the lowest cost. This is consistent with our previous findings for ODs with the largest power in SW-CRTs. Comparing all six ODs, we conclude that optimal closed-cohort CRXO trials are global ODs, yielding both the lowest cost and largest power.
JASA Other · 发表于 2025-08-11
František Bartoš, Alexandra Sarafoglou, Henrik R. Godmann, Amir Sahrani, David Klein Leunk, Pierre Y. Gui, David Voss, Kaleem Ullah, Malte Zoubek, Franziska Nippold, Frederik Aust, Felipe Fontana Vieira, Chris-Gabriel Islam, Anton J. Zoubek, Sara Shabani, Jonas Petter, Ingeborg B. Roos, Adam Finnemann, Aaron B. Lob, Madlen F. Hoffstadt, Jason Nak, Jill de Ron, Koen Derks, Karoline Huth, Sjoerd Terpstra, Thomas Bastelica, Magda Matetovici, Vincent L. Ott, Andreea S. Zetea, Katharina Karnbach, Michelle C. Donzallaz, Arne John, Roy M. Moore, Franziska Assion, Riet van Bork, Theresa E. Leidinger, Xiaochang Zhao, Adrian Karami Motaghi, Ting Pan, Hannah Armstrong, Tianqi Peng, Mara Bialas, Joyce Y.-C. Pang, Bohan Fu, Shujun Yang, Xiaoyi Lin, Dana Sleiffer, Miklos Bognar, Balazs Aczel, Eric-Jan Wagenmakers
摘要
Many people have flipped coins but few have stopped to ponder the statistical and physical intricacies of the process. We collected 350,757 coin flips to test the counterintuitive prediction from a physics model of human coin tossing developed by Diaconis, Holmes, and Montgomery (DHM; 2007). The model asserts that when people flip an ordinary coin, it tends to land on the same side it started. Our data support this prediction: the coins landed on the same side more often than not, Pr(same side)=0.508, 95% credible interval (CI) [0.506, 0.509], BFsame−side bias=2359. Furthermore, the data revealed considerable between-people variation in the degree of this same-side bias. Our data also confirmed the generic prediction that when people flip an ordinary coin—with the initial side-up randomly determined—it is equally likely to land heads or tails:Pr(heads)=0.500, 95% CI [0.498, 0.502], BFheads−tails bias=0.182. Additional analyses revealed that the within-people same-side bias decreased as more coins were flipped, an effect that is consistent with the possibility that practice makes people flip coins in a less wobbly fashion. Our data therefore provide strong evidence that when some (but not all) people flip a fair coin, it tends to land on the same side it started. *(abstract via OpenAlex)*
Biometrics Survival Analysis Spatial & Time Series · 发表于 2025-08-08
Yichen Lou, Mingyue Du, Xinyuan Song
摘要
There exists a substantial body of literature that discusses regression analysis of interval-censored failure time data and also many methods have been proposed for handling the presence of a cured subgroup. However, only limited research exists on the problems incorporating change points, with or without a cured subgroup, which can occur in various contexts such as clinical trials where disease risks may shift dramatically when certain biological indicators exceed specific thresholds. To fill this gap, we consider a class of partly linear transformation models within the mixture cure model framework and propose a sieve maximum likelihood estimation approach using Bernstein polynomials and piecewise linear functions for inference. Additionally, we provide a data-driven adaptive procedure to identify the number and locations of change points and establish the asymptotic properties of the proposed method. Extensive simulation studies demonstrate the effectiveness and practical utility of the proposed methods, which are applied to the real data from a breast cancer study that motivated this work.
SMMR Spatial & Time Series Bayesian Methods · 发表于 2025-08-08
Garazi Retegui, Alan E Gelfand, Jaione Etxeberria, María Dolores Ugarte
摘要
Disease mapping attempts to explain observed health event counts across areal units, typically using Markov random field models. These models rely on spatial priors to account for variation in raw relative risk or rate estimates. Spatial priors introduce some degree of smoothing, wherein, for any particular unit, empirical risk or incidence estimates are either adjusted towards a suitable mean or incorporate neighbor-based smoothing. While model explanation may be the primary focus, the literature lacks a comparison of the amount of smoothing introduced by different spatial priors. Additionally, there has been no investigation into how varying the parameters of these priors influences the resulting smoothing. This study examines seven commonly used spatial priors through both simulations and real data analyses. Using areal maps of peninsular Spain and England, we analyze smoothing effects using two datasets with associated populations at risk. We propose empirical metrics to quantify the smoothing achieved by each model and theoretical metrics to calibrate the expected extent of smoothing as a function of model parameters. We employ areal maps in order to quantitatively characterize the extent of smoothing within and across the models as well as to link the theoretical metrics to the empirical metrics.
SiM Causal Inference Survival Analysis · 发表于 2025-08-08
Patrick van Hage, Saskia le Cessie, Marissa C. van Maaren, Hein Putter, Nan van Geloven
摘要
Covariate imbalance between treatment groups makes it difficult to compare cumulative incidence curves in competing risk analyses. In this paper, we discuss different methods to estimate adjusted cumulative incidence curves, including inverse probability of treatment weighting and outcome regression modeling. For these methods to work, correct specification of the propensity score model or outcome regression model, respectively, is needed. We introduce a new doubly robust estimator, which requires correct specification of only one of the two models. We conduct a simulation study to assess the performance of these three methods, including scenarios with model misspecification of the relationship between covariates and treatment and/or outcome. We illustrate their usage in a cohort study of breast cancer patients estimating covariate‐adjusted marginal cumulative incidence curves for recurrence, second primary tumor development, and death after undergoing mastectomy treatment or breast‐conserving therapy. Our study points out the advantages and disadvantages of each covariate adjustment method when applied in competing risk analysis.
JASA High-Dimensional Spatial & Time Series · 发表于 2025-08-08
Anders B. Kock, Rasmus S. Pedersen, Jesper R.-V. Sørensen
摘要
Lasso-type estimators are routinely used to estimate high-dimensional time series models. The theoretical guarantees established for these estimators typically require the penalty level to be chosen in a suitable fashion often depending on unknown population quantities. Furthermore, the resulting estimates and the number of variables retained in the model depend crucially on the chosen penalty level. However, there is currently no theoretically founded guidance for this choice in the context of high-dimensional time series. Instead, one resorts to selecting the penalty level in an ad hoc manner using, e.g., information criteria or cross-validation. We resolve this problem by considering estimation of the perhaps most commonly employed multivariate time series model, the linear vector autoregressive (VAR) model, and propose versions of the Lasso, post-Lasso, and square-root Lasso estimators with penalization chosen in a fully data-driven way. The theoretical guarantees that we establish for the resulting estimation and prediction errors match those currently available for methods based on infeasible choices of penalization. We thus provide a first solution for choosing the penalization in high-dimensional time series models. *(abstract via OpenAlex)*
SiM Clinical Trials Testing & Uncertainty · 发表于 2025-08-08
David S. Robertson, Thomas Burnett, Babak Choodari‐Oskooei, Munya Dimairo, Michael Grayling, Philip Pallmann, Thomas Jaki
摘要
In adaptive clinical trials, the conventional confidence interval (CI) for a treatment effect is prone to undesirable properties such as undercoverage and potential inconsistency with the final hypothesis testing decision. Accordingly, as is stated in recent regulatory guidance on adaptive designs, there is the need for caution in the interpretation of CIs constructed during and after an adaptive clinical trial. However, it may be unclear which of the available CIs in the literature are preferable. This paper is the second in a two‐part series that explores CIs for adaptive trials. Part I provided a methodological review of approaches to construct CIs for adaptive designs. In this paper (Part II), we present an extended case study based around a two‐stage group sequential trial, including a comprehensive simulation study of the proposed CIs for this setting. This facilitates an expanded description of considerations around what makes for an effective CI procedure following an adaptive trial. We show that the CIs can have notably different properties. Finally, we propose a set of guidelines for researchers around the choice of CIs and the reporting of CIs following an adaptive design.
SiM Clinical Trials Testing & Uncertainty · 发表于 2025-08-08
David S. Robertson, Thomas Burnett, Babak Choodari‐Oskooei, Munya Dimairo, Michael Grayling, Philip Pallmann, Thomas Jaki
摘要
Regulatory guidance notes the need for caution in the interpretation of confidence intervals (CIs) constructed during and after an adaptive clinical trial. Conventional CIs of the treatment effects are prone to undercoverage (as well as other undesirable properties) in many adaptive designs (ADs) because they do not take into account the potential and realized trial adaptations. This paper is the first in a two‐part series that explores CIs for adaptive trials. It provides a comprehensive review of the methods to construct CIs for ADs, while the second paper illustrates how to implement these in practice and proposes a set of guidelines for trial statisticians. We describe several classes of techniques for constructing CIs for adaptive clinical trials before providing a systematic literature review of available methods, classified by the type of AD. As part of this, we assess, through a proposed traffic light system, which of several desirable features of CIs (such as achieving nominal coverage and consistency with the hypothesis test decision) each of these methods holds.
SiM Other · 发表于 2025-08-08
Qi Wang, Ann Duerr, Fei Gao
摘要
Cross‐sectional HIV incidence estimation leverages recency test results to determine the HIV incidence of a population of interest, where recency test uses biomarker profiles to infer whether an HIV‐positive individual was “recently” infected. This approach possesses an obvious advantage over the conventional cohort follow‐up method since it avoids longitudinal follow‐up and repeated HIV testing. In this manuscript, we consider the extension of cross‐sectional incidence estimation to estimate the incidence of a different target population, addressing potential population heterogeneity. We propose a general framework that incorporates two scenarios: one when the target population is a subset of the population with cross‐sectional recency testing data and the other with an external target population. In addition, we propose estimators to incorporate HIV subtypes, a special type of covariate that modifies the properties of recency tests, into our framework. Through simulation studies and a data application, we demonstrate the performance of the proposed methods. We conclude with a discussion on sensitivity analysis and future work to improve our framework.
SiM Nonparametric & Semiparametric · 发表于 2025-08-07
Anderson Bussing, Giampiero Marra, Daping Fan, Russell Shinohara, Danni Tu, Yen‐Yi Ho
摘要
Advancements in single‐cell RNA‐sequencing (scRNA‐seq) technologies generate a wealth of gene expression data that provide exciting opportunities for studying gene‐gene interactions systematically at individual cell resolution. Genetic interactions within a cell are tightly regulated and often highly dynamic in response to internal cellular signals and external stimuli. Evidence of these dynamic interactions can often be observed in scRNA‐seq data by examining conditional co‐expression changes. Existing approaches for studying these dynamic interaction changes in scRNA‐seq data do not address the multi‐subject hierarchical design commonly considered in single‐cell experiments. In this paper, we propose a Mixed‐effects framework for differential Coexpression and transcriptional interaction modeling in Single‐Cell RNA‐seq (scCOSMiX) to account for the cell‐cell correlation from the same individual. The proposed copula‐based approach allows the zero‐inflation, marginal, and association parameters to be modeled as functions of covariates with subject‐level random effects, to enable analyses to be tailored to the data under consideration. A series of simulation analyses were conducted to evaluate and compare the performance of scCOSMiX to other existing approaches. We applied the proposed method to both droplet and plate‐based scRNA‐seq data sets GSE266919 and GSE108989 to illustrate its applicability across distinct scRNA‐seq experimental protocols.
Biometrika Causal Inference · 发表于 2025-08-07
Andrew Gelman, Jonas M Mikhaeil
摘要
Summary: It has been proposed in medical decision analysis to express the ‘first, do no harm’ principle as an asymmetric utility function in which the loss from killing a patient would count more than the gain from saving a life. Such a utility depends on unrealized potential outcomes, and we show how this yields a paradoxical decision recommendation in a simple hypothetical example involving games of Russian roulette. The problem is resolved if we abandon the stable unit treatment value assumption and allow the potential outcomes to be random variables. This leads us to conclude that, if you are interested in this sort of asymmetric utility function, you need to move to the stochastic potential outcome framework. We discuss the implications of the choice of parameterization in this setting.
SiM Survival Analysis Missing Data & Measurement Error Nonparametric & Semiparametric · 发表于 2025-08-07
Haolin Li, Haibo Zhou, David Couper, Jianwen Cai
摘要
Case‐cohort and generalized case‐cohort study designs are widely used in epidemiological studies as a cost‐effective alternative to much larger cohort studies while achieving similar efficiency. Current research mostly focuses on the estimation and inference of semiparametric survival models, with limited attention directed towards nonparametric survival predictions within these study designs. In this paper, we propose to use the random survival forest with multiple imputation by chained equation (RSF‐MICE) and the random survival forest with substantive model compatible imputation (RSF‐SMCI) for survival prediction in case‐cohort and generalized case‐cohort studies. Simulation studies demonstrate superior finite‐sample performance for both proposed methods in various situations. We also apply our new approach to predict the incident diabetes in an analysis of a generalized case‐cohort study conducted as a part of the Atherosclerosis Risk in Communities Study.
SiM Other · 发表于 2025-08-07
Alan Herschtal
摘要
There has been growing awareness recently that conventional models for count data, such as the Negative Binomial model and zero inflated models, often yield poor fit and sub‐optimal performance when applied to real‐world count data problems. In response, a new, more flexible model for count data, the Poisson‐Beta model, has started to attract attention. The Poisson‐Beta model is a Poisson mixture where the underlying mixing distribution is a scaled Beta density. However, because its density function cannot be expressed in closed form, its use has been limited to very simple applications such as parameter estimation. This work presents a method of overcoming the computational complexity issues associated with the Poisson‐Beta density to allow its application to problems of far greater complexity, enabling it to be used to model response variables in multivariate regression. This work additionally demonstrates that Poisson‐Beta regression compares favorably to a range of commonly used regression models for count response data, achieving narrower confidence intervals and superior power.
SiM Clinical Trials Causal Inference Nonparametric & Semiparametric · 发表于 2025-08-07
Emily Shives, Yared Gurmu, Wonyul Lee, Emily Morris, Yan Wang
摘要
Many rare disease clinical trials are underpowered to detect a moderate treatment effect of an investigational product due to the limited number of participants available for the trials. In addition, given the complex, multisystemic nature of many rare diseases, it is challenging to confidently prespecify a single primary efficacy endpoint that is applicable to all trial participants with a heterogeneous clinical manifestation of their disease. Traditional trial designs and analysis methods often used in more common diseases to analyze the same endpoint(s) for all patients may be inefficient or impractical for a rare disease with heterogeneous clinical manifestations. To address these issues, we propose a novel trial design and analytic approach that allows for an evaluation of stratum‐specific efficacy endpoints in a broader population of participants. We develop several nonparametric global test methods that can accommodate the novel design and provide global evaluation of treatment effects. Using a case example in patients with Fabry disease, our simulation studies illustrate that the novel design evaluated using the global test methods may be more sensitive to detect a treatment effect compared to the traditional design that uses the same endpoint(s) for all patients.
SiM Survival Analysis Clinical Trials · 发表于 2025-08-07
Yangqing Deng, Meiling Hao, Shao Hui Huang, Geoffrey Liu, John R. de Almeida, Wei Xu
摘要
Overall survival has been used as the primary endpoint for many randomized trials that aim to examine whether a new treatment is non‐inferior to the standard treatment or placebo control. When a new treatment is indeed non‐inferior in terms of survival, it may be important to assess other outcomes including health utility. However, analyzing health utility scores in a secondary analysis may have limited power since the primary objectives of the original study design may not include health utility. To comprehensively consider both survival and health utility, we developed a composite endpoint, HUS (Health Utility‐adjusted Survival), which combines both survival and utility. HUS has been shown to be able to increase statistical power and potentially reduce the required sample size compared to the standard overall survival endpoint. Nevertheless, the asymptotic properties of the test statistics of the HUS endpoint have yet to be fully established. Besides that, the standard version of HUS cannot be applied to or has limited performance in certain scenarios, where extensions are needed. In this manuscript, we propose various methodological extensions of HUS and derive the asymptotic distributions of the test statistics. By comprehensive simulation studies and a data application using retrospective data based on a translational patient cohort in Princess Margaret Cancer Centre, we demonstrate the better efficiency and feasibility of HUS compared to different methods.
SiM Missing Data & Measurement Error Causal Inference · 发表于 2025-08-07
Minxin Lu, Annie Green Howard, Penny Gordon‐Larsen, Katie A. Meyer, Hsiao‐Chuan Tien, Shufa Du, Huijun Wang, Bing Zhang, Michael R. Kosorok
摘要
Optimal individualized treatment decision‐making has improved health outcomes in recent years. The value function is commonly used to evaluate the goodness of an individualized treatment decision rule. Despite recent advances, comparing value functions between different treatment decision rules or constructing confidence intervals around value functions remains difficult. We propose a t ‐test based method applied to a test set that generates valid p ‐values to compare value functions between a given pair of treatment decision rules when some of the data are missing. We demonstrate the ease in use of this method and evaluate its performance via simulation studies and apply it to the China Health and Nutrition Survey data.
SiM Missing Data & Measurement Error Diagnostics & Prediction · 发表于 2025-08-07
Junhui Mi, Rahul D. Tendulkar, Sarah M. C. Sittenfeld, Sujata Patil, Emily C. Zabor
摘要
Methods to handle missing data have been extensively explored in the context of estimation and descriptive studies, with multiple imputation being the most widely used method in clinical research. However, in the context of clinical risk prediction models, where the goal is often to achieve high prediction accuracy and to make predictions for future patients, there are different considerations regarding the handling of missing covariate data. As a result, deterministic imputation is better suited to the setting of clinical risk prediction models, since the outcome is not included in the imputation model and the imputation method can be easily applied to future patients. In this paper, we provide a tutorial demonstrating how to conduct bootstrapping followed by deterministic imputation of missing covariate data to construct and internally validate the performance of a clinical risk prediction model in the presence of missing data. Simulation study results are provided to help guide when imputation may be appropriate in real‐world applications.
SiM Longitudinal Data Survival Analysis Bayesian Methods · 发表于 2025-08-07
Feng Gu, Jiaqing Chen, Jinjing Wang, Yibo Long, Xiaofan Wang, Yangxin Huang
摘要
In the realm of clinical medical research, semi‐competing risks data are usually observed in practice, yet there are few studies on the joint models of longitudinal and semi‐competing risks data. In this paper, a joint model for longitudinal and semi‐competing risks data is proposed. Based on the expectile regression, a linear mixed‐effects longitudinal sub‐model is formulated, and a Cox proportional hazards survival sub‐model is considered under the framework of semi‐competing risks. The two sub‐models are linked by a shared longitudinal trajectory function. To accommodate the time‐varying relationship between the longitudinal response variable and covariates, as well as to introduce flexibility to the structural linkage between longitudinal and survival processes, we incorporate the time‐varying coefficients into the joint model in the form of nonparametric functions. The simultaneous Bayesian inference method is utilized to estimate the model parameters, which not only overcomes the convergence problem, but also improves the accuracy of the parameter estimation while effectively reducing the computational burden. The simulation studies are conducted to assess the performance of the proposed joint model and methodology. Finally, we analyze a dataset from the Multicenter AIDS Cohort Study to illustrate the real application of the proposed model and method. In both simulation studies and empirical analyses, joint modeling methods demonstrate performance that meets expected effects.
SiM Causal Inference Clinical Trials · 发表于 2025-08-07
George Hripcsak, Linying Zhang, Yong Chen, Kelly Li, Marc A. Suchard, Patrick B. Ryan, Martijn J. Schuemie
摘要
Propensity score adjustment addresses confounding by balancing covariates in subject treatment groups through matching, stratification, or weighting. Diagnostics test the success of adjustment. For example, if the standardized mean difference (SMD) for a relevant covariate exceeds a threshold like 0.1, the covariate is considered imbalanced and the study may be biased. Unfortunately, for studies with small or moderate numbers of subjects, the probability of identifying a study as biased because of chance imbalance can be grossly larger than a given nominal level like 0.05, yet that chance imbalance may not cause significant bias. In this paper, we illustrate that chance imbalance is operative in real‐world settings even for moderate sample sizes of 2000. We identify a previously unrecognized challenge that as meta‐analyses increase the precision of an effect estimate, the diagnostics must also undergo meta‐analysis for a corresponding increase in precision. We propose an alternative diagnostic that checks whether the SMD statistically significantly exceeds the threshold. Through simulation and real‐world data, we find that this diagnostic achieves a better trade‐off of type 1 error rate and power than standard nominal threshold tests and not testing for sample sizes from 250 to 4000 and for 20 to 100 000 covariates. We confirm that in network studies, meta‐analysis of effect estimates must be accompanied by meta‐analysis of the diagnostics or else systematic confounding may overwhelm the estimated effect. Our procedure supports the review of large numbers of covariates, enabling more rigorous diagnostics.
SiM Bayesian Methods Longitudinal Data Causal Inference · 发表于 2025-08-07
Lori P. Selby, Ruoqian Liu, Jeffrey R. Wilson
摘要
Longitudinal studies with binary outcomes often involve time‐dependent covariates that evolve alongside outcomes, introducing feedback effects and endogeneity. Standard approaches, such as Generalized Estimating Equations (GEE) and Generalized Linear Mixed Models (GLMM), typically assume covariate exogeneity, leading to biased and inconsistent estimates when feedback is present. We propose a unified three‐step hierarchical Bayesian framework to address these challenges. First, the Generalized Method of Moments (GMM) identifies valid instruments to correct for endogeneity. Second, a Bayesian hierarchical logistic regression model estimates outcome probabilities while accounting for within‐subject correlation. Third, a reversal model explicitly captures feedback by modeling time‐dependent covariates as outcomes influenced by prior responses. Through simulations, we demonstrate that the proposed framework substantially reduces bias, lowers root mean squared error (RMSE), and improves uncertainty quantification compared to traditional methods, especially under moderate to strong feedback. We illustrate the practical utility of the approach using a synthetic longitudinal diabetes dataset, where feedback between prior glucose levels and self‐monitoring behavior meaningfully alters inference. This integrated framework provides a flexible and interpretable solution for longitudinal binary data analysis, particularly in clinical, behavioral, and public health research.
SiM Clinical Trials · 发表于 2025-08-07
Yinuo Zhang, Shein‐Chung Chow
摘要
In recent years, benefit–risk assessment (BRA) has become a crucial tool in guiding regulatory decisions regarding the safety and efficacy of investigational treatments. Following the FDA's recent guidance on the BRA, we statistically develop a confidence ellipse approach that considers both safety and efficacy indices. This method addresses limitations in existing BRA frameworks by providing a visual and quantitative tool that accounts for uncertainties and heterogeneities in clinical trial data. We introduce three novel indices: the Net Benefit Index (NBI), Relative Benefit Index (RBI), and Success Rate Index (SRI), offering a comprehensive assessment of treatment performance. Through extensive simulations, we compared the confidence ellipse method with established BRA techniques such as global benefit–risk (GBR) assessment (GBR), multi‐criteria decision analysis (MCDA), and stochastic multi‐criteria acceptability analysis (SMAA). Our results showed the confidence ellipse method's robustness, particularly with larger sample sizes, and demonstrated decreasing sensitivity as sample sizes increased, reflecting enhanced stability. To illustrate the method's practical application, we present a hypothetical Phase 2 clinical trial comparing a new drug combined with chemoradiotherapy against placebo for locally advanced squamous cell carcinoma of the head and neck. The confidence ellipse approach successfully provided a nuanced benefit–risk assessment, incorporating both unweighted and weighted analyses for adverse events. Overall, the confidence ellipse method is a robust, adaptable, and interpretable tool for benefit–risk assessment, offering valuable visual and quantitative insights for decision‐making in modern clinical trials and regulatory processes.
SiM Other · 发表于 2025-08-07
Nicholas Steyn, Kris V. Parag, Robin N. Thompson, Christl A. Donnelly
摘要
Renewal models are widely used in statistical epidemiology as semi‐mechanistic models of disease transmission. While primarily used for estimating the instantaneous reproduction number, they can also be used for generating projections, estimating elimination probabilities, modeling the effect of interventions, and more. We demonstrate how simple sequential Monte Carlo methods (also known as particle filters) can be used to perform inference on these models. Our goal is to acquaint a reader who has a working knowledge of statistical inference with these methods and models and to provide a practical guide to their implementation. We focus on these methods' flexibility and their ability to handle multiple statistical and other biases simultaneously. We leverage this flexibility to unify existing methods for estimating the instantaneous reproduction number and generating projections. A companion website SMC and epidemic renewal models provides additional worked examples, self‐contained code to reproduce the examples presented here, and additional materials.
SiM Genetics & Omics Econometrics & Economics · 发表于 2025-08-07
Roberto Ascari, Sonia Migliorati, Andrea Ongaro
摘要
Motivated by the challenges in analyzing gut microbiome and metagenomic data, this paper introduces a novel mixture distribution for multivariate counts and a regression model built upon it. The flexibility and interpretability of the proposed distribution accommodate both negative and positive dependence among taxa and are accompanied by numerous theoretical properties, including explicit expressions for inter‐ and intraclass correlations, thereby providing a powerful tool for understanding complex microbiome interactions. Furthermore, the regression model based on this distribution facilitates the clear identification and interpretation of relationships between taxa and covariates by modeling the marginal mean of the multivariate response (i.e., taxa counts). Inference is performed using a tailored Hamiltonian Monte Carlo estimation method combined with a spike‐and‐slab variable selection procedure. Extensive simulation studies and an application to a human gut microbiome dataset highlight the proposed model's substantial improvements over competing models in terms of fit, interpretability, and predictive performance.
SiM Latent Variables & Mixtures Bayesian Methods Longitudinal Data · 发表于 2025-08-07
Kai Kang, Qinxia Wang, Zhanpeng Xu, Yuanjia Wang
摘要
Patients affected by neurological disorders usually present substantial heterogeneity in multi‐domain biomarkers and clinical measures. This heterogeneity arises from differences in disease stage, unique characteristics, and membership in distinct latent subtypes. Exploring such complex heterogeneity and identifying disease progression‐related markers is crucial for early diagnosis and developing timely and targeted interventions. This paper proposes a mixture exponential family trajectory model to integrate markers from multiple modalities to learn the disease progression. We incorporate continuous neuroimaging and microRNA sequencing biomarkers, categorical clinical symptoms, and ordinal cognitive markers using appropriate exponential family distributions with lower‐dimensional latent factors. The mixture model assigns subtype‐specific parameters to these distributions for each mixture component, enabling the characterization of patients in heterogeneous latent subgroups. The proposed model can also describe the nonlinear trajectory of disease deterioration and provide a temporal sequence of decline for each marker. We develop a Bayesian estimation procedure coupled with efficient Markov chain Monte Carlo (MCMC) sampling schemes to perform statistical inference for the mixture model. The proposed method is assessed through extensive simulation studies and an application to Parkinson's Progression Markers Initiative (PPMI) to learn the temporal ordering and subtypes of neurodegeneration of Parkinson's disease (PD).
Biometrics Causal Inference Longitudinal Data Bayesian Methods · 发表于 2025-08-06
Sidi Wang, Satrajit Roychoudhury, Kelley M Kidwell
摘要
For progressive rare diseases like Duchenne muscular dystrophy (DMD), evaluating disease burden by measuring the totality of evidence from outcome data over time per patient can be highly informative, especially regarding how a new treatment impacts disease progression and functional outcomes. This paper focuses on new statistical approaches for analyzing data generated over time in a small sample, sequential, multiple assignment, randomized trial (snSMART), with an application to DMD. In addition, the use of external control data can enhance the statistical and operational efficiency in rare disease drug development by solving participant scarcity issues and ethical challenges. We employ a two-step robust meta-analytic approach to leverage external control data while adjusting for important baseline confounders and potential conflicts between external controls and trial data. Furthermore, our approach integrates important baseline covariates to account for patient heterogeneity and introduces a novel piecewise model to manage stage-wise treatment assignments. By applying this methodology to a case study in DMD research, we not only demonstrate the practical application and benefits of our approach but also highlight its potential to mitigate challenges in rare disease trials. Our findings advocate for a more nuanced and statistically robust analysis of treatment effects, thereby improving the reliability of clinical trial results.
SMMR Bayesian Methods Clinical Trials · 发表于 2025-08-06
Alessandra Giovagnoli, Monia Lupparelli
摘要
Starting from a Bayesian perspective, this paper proposes a novel response adaptive randomization rule based on the use of the predictive distribution. The intent is to design a randomized mechanism that favors the allocation of the next patient to the “best” treatment, considering the expected future outcomes obtained by combining accrued data with prior information. This predictive rule also stems from a decision-theoretic approach. The method is driven by patients’ beneficial motivations, fully debated in this work, but also accounts for essential inferential purposes in clinical trials discussed within the framework of frequentist inference. Some asymptotic properties of the proposed rule are proved and also shown through numerical studies, which compare this method with other competing ones, as the notable Thompson rule for the special case of binary outcomes.
JASA High-Dimensional · 发表于 2025-08-05
Siyao Wang, Miles E. Lopes
摘要
Due to the broad applications of elliptical models, there is a long line of research on goodness-of-fit tests for empirically validating them. However, the existing literature on this topic is generally confined to low-dimensional settings, and to the best of our knowledge, there are no established goodness-of-fit tests for elliptical models that are supported by theoretical guarantees in high dimensions. In this paper, we propose a new goodness-of-fit test for this problem, and our main result shows that the test is asymptotically valid when the dimension and sample size diverge proportionally. Remarkably, it also turns out that the asymptotic validity of the test requires no assumptions on the population covariance matrix. With regard to numerical performance, we confirm that the empirical level of the test is close to the nominal level across a range of conditions, and that the test is able to reliably detect non-elliptical distributions. Moreover, when the proposed test is specialized to the problem of testing normality in high dimensions, we show that it compares favorably with a state-of-the-art method, and hence, this way of using the proposed test is of independent interest. *(abstract via OpenAlex)*
JASA Survival Analysis · 发表于 2025-08-05
Nicole Augustin, Axel Albrecht, Karim Anaya-Izquierdo, Alice Davis, Stefan Meining, Heike Puhlmann, Simon Wood
摘要
Using German forest health monitoring data we investigate the main drivers leading to tree mortality and the association between defoliation and mortality; in particular (a) whether defoliation is a proxy for other covariates (climate, soil, water budget); (b) whether defoliation is a tree response that mitigates the effects of climate change and (c) whether there is a threshold of defoliation which could be used as an early warning sign for irreversible damage. Results show that environmental drivers leading to tree mortality differ by species, but some are always required in the model. The defoliation effect on mortality differs by species but it is always strong and monotonic. There is some evidence that a defoliation threshold exists for spruce, fir and beech.We model tree survival with a smooth additive Cox model allowing for random effects taking care of dependence between neighbouring trees and non-linear functions of spatial time varying and functional predictors on defoliation, climate, soil and hydrology characteristics. Due to the large sample size and large number of parameters, we use parallel computing combined with marginal discretization of covariates. We propose a ’boost forward penalise backward’ scheme based on combining component-wise gradient boosting with integrated backward selection. *(abstract via OpenAlex)*
JASA Other · 发表于 2025-08-05
Xianshi Yu, Ji Zhu
摘要
While relations among individuals make an important part of data with scientific and business interests, existing statistical modeling of relational data has mainly been focusing on dyadic relations, that is, those between two individuals.This article addresses the less studied, though commonly encountered, polyadic relations that can involve more than two individuals.In particular, we propose a new latent space model for hypergraphs using determinantal point processes, which is driven by the diversity within hyperedges and each node's popularity.This model mechanism is in contrast to existing hypergraph models, which are predominantly driven by similarity rather than diversity.Additionally, the proposed model accommodates broad types of hypergraphs, with no restriction on the cardinality and multiplicity of hyperedges, which previous models often have.Consistency and asymptotic normality of the maximum likelihood estimates of the model parameters have been established.The proof is challenging, owing to the special configuration of the parameter space.Further, we apply the projected accelerated gradient descent algorithm to obtain the parameter estimates, and we show its effectiveness in simulation studies.We also demonstrate an application of the proposed model on the What's Cooking data and present the embedding of food ingredients learned from cooking recipes using the model.Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA Genetics & Omics · 发表于 2025-08-05
Ye Yue, Yicong Mao, Timothy D. Read, Veronika Fedirko, Glen A. Satten, Xuan Chen, Xiang Zhan, Yi-Juan Hu
摘要
The most widely used technologies for profiling microbial communities are 16S marker-gene sequencing and shotgun metagenomic sequencing. Surprisingly, many microbiome studies have performed both experiments on the same cohort of samples. The two sequencing datasets often reveal consistent patterns of microbial signatures, suggesting that an integrative analysis of both datasets could enhance the testing power for these signatures. However, differential experimental biases, partially overlapping samples, and uneven library sizes pose tremendous challenges when combining the two datasets. In this article, we introduce the first method of this kind, named Com-2seq, that combines the two datasets for testing differential abundance at the genus level as well as the community level while overcoming these difficulties. Our simulation studies demonstrate that Com-2seq substantially enhances statistical efficiency over analysis of a single dataset and outperforms two ad hoc approaches to integrative analysis. In analysis of real microbiome data, Com-2seq uncovered scientifically plausible findings, namely, the association of Butyrivibrio, Gemella and Ignavigranum with prediabetes status, which would have been missed by analyzing a single dataset. Butyrivibrio failed to reach the significance level in the analysis of each dataset despite showing a consistent trend; Gemella and Ignavigranum failed to produce adequate data in the 16S experiment. *(abstract via PubMed)*
JASA Causal Inference · 发表于 2025-08-05
Jieru Shi, Zhenke Wu, Walter Dempsey
摘要
The use of smart devices (e.g., smartphones, smartwatches) and other wearables to deliver digital interventions to improve health outcomes has grown significantly in the past few years. Mobile health (mHealth) systems are excellent tools for the delivery of adaptive interventions that aim to provide the right type/amount of support, at the right time, by adapting to an individual's changing context. Micro-randomized trials (MRTs) are an increasingly common experimental design that are the main source for data-driven evidence of mHealth intervention effectiveness. To assess time-varying causal effect moderation in an MRT, individuals are intensively randomized to receive treatment over time. In addition, measurements, including individual characteristics, and context are also collected throughout the study. The effective utilization of covariate information to improve inferences regarding causal effects has been well-established in the context of randomized control trials (RCTs), where covariate adjustment is applied to leverage baseline data to address chance imbalances and improve the asymptotic efficiency of causal effect estimation. However, the application of this approach to longitudinal data, such as MRTs, has not been thoroughly explored. Recognizing the connection to Neyman Orthogonality, we propose a straightforward and intuitive method to improve the efficiency of moderated causal excursion effects by incorporating auxiliary variables. We compare the robust standard errors of our method with those of the benchmark method. The efficiency gain of our approach is demonstrated through simulation studies and an analysis of data from the Intern Health Study (NeCamp et al., 2020). *(abstract via PubMed)*
JASA Networks & Graphs Testing & Uncertainty · 发表于 2025-08-05
Meijia Shao, Dong Xia, Yuan Zhang, Qiong Wu, Shuo Chen
摘要
Two-sample hypothesis testing for network comparison presents many significant challenges, including: leveraging repeated network observations and known node registration, but without requiring them to operate; relaxing strong structural assumptions; achieving finite-sample higher-order accuracy; handling different network sizes and sparsity levels; fast computation and memory parsimony; controlling false discovery rate (FDR) in multiple testing; and theoretical understandings, particularly regarding finite-sample accuracy and minimax optimality. In this article, we develop a comprehensive toolbox, featuring a novel main method and its variants, all accompanied by strong theoretical guarantees, to address these challenges. Our method outperforms existing tools in speed and accuracy, and it is proved power-optimal. Our algorithms are user-friendly and versatile in handling various data structures (single or repeated network observations; known or unknown node registration). We also develop an innovative framework for offline hashing and fast querying as a very useful tool for large network databases. We showcase the effectiveness of our method through comprehensive simulations and applications to two real-world datasets, which revealed intriguing new structures. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
Biometrika Other · 发表于 2025-08-05
R Caprio, A M Johansen
摘要
Summary: We present a new framework for analysing the expectation-maximization (em) algorithm. Drawing on recent advances in the theory of gradient flows over Euclidean–Wasserstein spaces, we extend techniques from alternating minimization in Euclidean spaces to the em algorithm, via its representation as coordinatewise minimization of the free energy. In so doing, we obtain finite-sample error bounds and exponential convergence of the em algorithm under a natural generalization of the log-Sobolev inequality. We further show that this framework naturally extends to several variants of the em algorithm, offering a unified approach for studying such algorithms.
JASA Causal Inference Machine Learning Optimization & Learning Theory · 发表于 2025-08-05
Zhengling Qi, Chenjia Bai, Zhaoran Wang, Lan Wang
摘要
In the literature of reinforcement learning (RL), off-policy evaluation is mainly focused on estimating a value of a target policy given the pre-collected data generated by some behavior policy. Motivated by the recent success of distributional RL in many practical applications, we study the distributional off-policy evaluation problem in the batch setting when the reward is multi-variate. We propose an offline Wasserstein-based approach to simultaneously estimate the joint distribution of a multivariate discounted cumulative reward given any initial state-action pair in the setting of an infinite-horizon Markov decision process. Finite sample error bound for the proposed estimator with respect to a modified Wasserstein metric is established in terms of both the number of trajectories and the number of decision points on each trajectory in the batch data. Extensive numerical studies are conducted to demonstrate the superior performance of our proposed method. *(abstract via OpenAlex)*
JASA Machine Learning · 发表于 2025-08-05
Yangxinyu Xie, Xiang Li, Tanwi Mallick, Weijie Su, Ruixun Zhang
摘要
Watermarking language models is essential for distinguishing between human and machine-generated text and thus maintaining the integrity and trustworthiness of digital communication. We present a novel green/red list watermarking approach that partitions the token set into “green” and “red” lists, subtly increasing the generation probability for green tokens. To correct token distribution bias, our method employs maximal coupling, using a uniform coin flip to decide whether to apply bias correction, with the result embedded as a pseudorandom watermark signal. Theoretical analysis confirms this approach’s unbiased nature and robust detection capabilities. Experimental results show that it outperforms prior techniques by preserving text quality while maintaining high detectability, and it demonstrates resilience to targeted modifications aimed at improving text quality. This research provides a promising watermarking solution for language models, balancing effective detection with minimal impact on text quality. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA Meta-Analysis & Data Integration Survival Analysis Testing & Uncertainty · 发表于 2025-08-05
Pierre Bayle, Jianqing Fan, Zhipeng Lou
摘要
Motivated by multi-center biomedical studies that cannot share individual data due to privacy and ownership concerns, we develop communication-efficient iterative distributed algorithms for estimation and inference in the high-dimensional sparse Cox proportional hazards model. We demonstrate that our estimator, even with a relatively small number of iterations, achieves the same convergence rate as the ideal full-sample estimator under very mild conditions. To construct confidence intervals for linear combinations of high-dimensional hazard regression coefficients, we introduce a novel debiased method, establish central limit theorems, and provide consistent variance estimators that yield asymptotically valid distributed confidence intervals. In addition, we provide valid and powerful distributed hypothesis tests for any coordinate element based on a decorrelated score test. We allow time-dependent covariates as well as censored survival times. Extensive numerical experiments on both simulated and real data lend further support to our theory and demonstrate that our communication-efficient distributed estimators, confidence intervals, and hypothesis tests improve upon alternative methods. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via OpenAlex)*
JASA Survival Analysis · 发表于 2025-08-05
Yangjianchen Xu, Donglin Zeng, D. Y. Lin
摘要
This article presents a general framework for checking the adequacy of the Cox proportional hazards model with interval-censored data, which arise when the event of interest is known only to occur over a random time interval. Specifically, we construct certain stochastic processes that are informative about various aspects of the model, that is, the functional forms of covariates, the exponential link function and the proportional hazards assumption. We establish their weak convergence to zero-mean Gaussian processes under the assumed model through empirical process theory. We then approximate the limiting distributions by Monte Carlo simulation and develop graphical and numerical procedures to check model assumptions and improve goodness of fit. We evaluate the performance of the proposed methods through extensive simulation studies and provide an application to the Atherosclerosis Risk in Communities Study. Supplementary materials for this article are available online, including a standardized description of the materials available for reproducing the work. *(abstract via PubMed)*